Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec:55:125-131.
doi: 10.1016/j.coph.2020.10.008. Epub 2020 Nov 21.

Epigenetics in β-cell adaptation and type 2 diabetes

Affiliations
Review

Epigenetics in β-cell adaptation and type 2 diabetes

Hyunki Kim et al. Curr Opin Pharmacol. 2020 Dec.

Abstract

Healthy pancreatic β-cells adapt to systemic insulin resistance to maintain normal blood glucose levels, and a failure of this adaptation leads to type 2 diabetes in humans. While genome-wide association studies have uncovered genetic variants that are associated with type 2 diabetes, it is still insufficient to explain the high prevalence of this disease. Epigenetics is the study of gene expression changes that do not involve DNA sequence alterations such as DNA methylation, histone modification, and non-coding RNAs. Over the last decade, a large number of studies have reported on the role of epigenetics in β-cell biology. In this review, we summarize the epigenetic mechanisms in β-cell adaptation and type 2 diabetes, including alterations in three-dimensional chromatin structure and RNA modifications.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Epigenetic regulation of β-cell adaptation Schematic representation summarizing the epigenetic mechanisms in β-cell adaptation. In response to systemic insulin resistance such as aging and obesity, β-cells adapt to external conditions by self-duplication, enhancing insulin secretion, and maintaining its mature identity. The figure created with BioRender.com.

References

    1. Halban PA, Polonsky KS, Bowden DW, Hawkins MA, Ling C, Mather KJ, Powers AC, Rhodes CJ, Sussel L, Weir GC: β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment. Diabetes Care 2014, 37:1751 LP–1758. - PMC - PubMed
    1. Prentki M, Nolan CJ: Islet β-cell failure in type 2 diabetes. J Clin Invest 2006, 116:1802–1812. - PMC - PubMed
    1. Weir GC, Gaglia J, Bonner-Weir S: Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes. Lancet Diabetes Endocrinol 2020, 8:249–256. - PMC - PubMed
    1. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M: Mechanisms of β-Cell Death in Type 2 Diabetes. Diabetes 2005, 54:S108 LP–S113. - PubMed
    1. Bensellam M, Jonas JC, Laybutt DR: Mechanisms of β;-cell dedifferentiation in diabetes: Recent findings and future research directions. J Endocrinol 2018, 236: R109–R143. - PubMed

Publication types